Search Results - "Vivancos, Pilar"

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma by Montoto, Silvia, Moreno, Carol, Domingo-Domenech, Eva, Estany, Cristina, Oriol, Albert, Altes, Albert, Besalduch, Joan, Pedro, Carme, Gardella, Santiago, Escoda, Lourdes, Asensio, Antoni, Vivancos, Pilar, Galan, Pilar, de Sevilla, Alberto Fernandez, Ribera, Josep M, Briones, Javier, Colomer, Dolors, Campo, Elias, Montserrat, Emili, Lopez-Guillermo, Armando, Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB) Spain

“…1 Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona; 2 Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona; 3 Department of Hematology,…”
Get full text

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial by Magnano, Laura, Montoto, Silvia, González-Barca, Eva, Briones, Javier, Sancho, Juan Manuel, Muntañola, Ana, Salar, Antonio, Besalduch, Joan, Escoda, Lourdes, Moreno, Carol, Domingo-Domenech, Eva, Estany, Cristina, Oriol, Albert, Altés, Albert, Pedro, Carmen, Gardella, Santiago, Asensio, Antoni, Vivancos, Pilar, Fernández de Sevilla, Alberto, Ribera, Josep María, Colomer, Dolors, Campo, Elias, López-Guillermo, Armando

“…Fludarabine combinations are very affective in follicular lymphoma (FL) with high rates of complete response and prolonged survival. However, late toxicities…”
Get full text

Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol by Oriol, A, Ribera, JM, Esteve, J, Guardia, R, Brunet, S, Bueno, J, Pedro, C, Llorente, A, Tormo, M, Besalduch, J, Sanchez, JM, Batlle, M, Vivancos, P, Carreras, E, Vila, JM, Julia, A, Sierra, J, Montserrat, E, Feliu, E, CETLAM AML-99

“…CETLAM Group, Catalonia, Spain. aoriol@ns.hugtip.scs.es BACKGROUND AND OBJECTIVES: The benefits of high-dose cytarabine, anthracyclines and hematopoietic stem…”
Get full text

Use of Granulocyte Colony-Stimulating Factor (G-CSF) Together with Induction and Intensification Chemotherapy (CT) in Adults with Primary Acute Myeloid Leukemia (AML) by Brunet, Salut, Perea, Granada, Ribera, Josep M., Esteve, Jordi, Tormo, Mar, Berlanga, Juan, Bueno, Javier, Llorente, Andreu, Moraleda, Jose M., Guardia, Ramon, Besalduch, Joan, Torres, Pio, de Llano, Maria Paz Queipo, Marti, Josep M., Pedro, Carmen, Bargay, Joan, Sanchez, Josep M., Vivancos, Pilar, Feliu, Evaristo, Montserrat, Emili, Sierra, Jorge

“…We analyzed the complete remission (CR) rate and toxicity in patients (pts) with “de novo” AML enrolled in an intensive CT protocol including induction and…”
Get full text

Tandem transplants with different high‐dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial by Lahuerta, Juan José, Grande, Carlos, Martínez‐Lopez, Joaquín, De La Serna, Javier, Toscano, Rosa, Ortiz, María Cruz, Larregla, Santiago, Conde, Eulogio, Insunza, Andrés, Gonzalez‐San Miguel, José David, Bargay, Juan, Cabrera, Rafael, García‐Ruiz, Juan Carlos, Albó, Carmen, García‐Alonso, Luis, Solano, Fernando, Vivancos, Pilar, León, Angel, San Miguel, Jesús

“…Between 1994 and 1999, 88 multiple myeloma (MM) patients were included in a phase II study to evaluate a tandem autologous stem cell transplantation (ASCT)…”
Get full text

Germline Polymorphisms Provide Strong Prognostic Information in Intermediate Risk Acute Myeloblastic Leukemia (AML) by Urbano-Ispizua, Alvaro, Brunet, Salut, Monzo, Mariano, Perea, Granada, Navarro, Alfons, Esteve, Jordi, Berlanga, Juan, Ribera, Josep-Maria, Bueno, Javier, Llorente, Andreu, Besalduch, Juan, Guardia, Ramon, Tormo, Mar, Pedro, Carmen, Sanchez, Juan-Maria, Torres, Pio, de Llano, Maria-Paz Queipo, Font, Llorens, Moraleda, Jose-Maria, Marti, Josep-Maria, Vivancos, Pilar, Peñarubia, Maria-Jesus, Nomdedeu, Josep, Montserrat, Emili, Sierra, Jorge

“…In this study we tested whether distinct patterns of functional genomic polymorphisms in genes involved in drug metabolic pathways (GSTT1, SULT1C2, CD-EX,…”
Get full text

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC) by Perea, Granada, Lasa, Adriana, Aventin, Anna, Domingo, Alicia, Villamor, Neus, de LLano, Maria Paz Queipo, Llorente, Andreu, Junca, Jordi, Palacios, Carlos, Fernandez, Cristalina, Guallart, Miquel, Font, Llorens, Tormo, Mar, Florensa, Lourdes, Bargay, Joan, Marti, Josep M., Vivancos, Pilar, Torres, Pio, Berlanga, Juan, Brunet, Salut, Sierra, Jorge, Nomdedeu, Josep F.

“…Objectives: To analyze MRD in 65 patients (pts) with good prognosis AML: 30 t(8;21) and 35 inv(16), using both FC and RT-PCR, and to investigate the prognostic…”
Get full text

Favourable effect of the combination of acute and chronic graft‐versus‐host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies by Brunet, Salut, Urbano‐Ispizua, Alvaro, Ojeda, Emilio, Ruiz, Dolores, Moraleda, José Ma, Díaz, Miguel Angel, Caballero, Dolores, Bargay, Joan, De La Rubia, Javier, Solano, Carlos, Zuazu, Javier, Diez, José Luis, De La Serna, Javier, Espigado, Idelfonso, Alegre, Adrián, Torres, J. Pio, Jurado, Manuel, Fernández, Manuel, Vivancos, Pilar, Carreras, Enric, Hernández, Fernando, Maldonado, Juan, Sierra, Jorge, Rozman, Ciril, Of Allogeneic–PBT, For The Spanish Group

“…To assess the influence of graft‐versus‐host disease (GVHD) on the outcome of patients with advanced haematological malignancies (AHM) who received a primary,…”
Get full text